179 studies found for:    Encephalitis
Show Display Options
RSS Create an RSS feed from your search for:
Encephalitis
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers
Conditions: Encephalitis;   Japanese Encephalitis
Interventions: Biological: Japanese encephalitis chimeric virus vaccine (JE-CV);   Biological: Japanese encephalitis live vaccine (SA14-14-2 vaccine) (CD.JEVAX®)
2 Completed Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers
Conditions: Encephalitis;   Japanese Encephalitis
Intervention:
3 Completed A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2
Conditions: Japanese Encephalitis;   Japanese Encephalitis Vaccine
Intervention: Biological: Live attenuated Japanese encephalitis vaccine SA14-14-2
4 Completed
Has Results
Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in Toddlers
Conditions: Japanese Encephalitis;   Japanese Encephalitis Virus Disease
Interventions: Biological: Live attenuated Japanese encephalitis chimeric virus vaccine;   Biological: Japanese encephalitis live attenuated vaccine (SA14 14 2 vaccine)
5 Recruiting A Phase II, Open Label Trial of a Vaccine (FSME-IMMUN 0.5 mL) Against Tick-borne Encephalitis (TBE) for NIAID Workers Manipulating Tick Borne Encephalitis Virus (TBEV) in the Laboratory
Conditions: Tick-Borne Encephalitis;   Encephalitis, Tick-Borne;   Tick-Borne Disease;   Glycoprotein E, Flavivirus;   NSI Protein, Flavivirus
Intervention: Biological: FSME-IMMUN 0.5ml Baxter
6 Completed Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
Condition: Encephalitis, Japanese B
Intervention: Biological: Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine
7 Completed
Has Results
Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population
Condition: Encephalitis
Interventions: Biological: IC51 Japanese Encephalitis;   Biological: Havrix®720;   Biological: Prevnar
8 Completed
Has Results
Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
Condition: Encephalitis, Japanese B
Intervention: Biological: Live attenuated SA 14-14-2 vaccine
9 Completed
Has Results
Immunogenicity and Safety of the Japanese Encephalitis Vaccine IC51 (IXIARO®, JESPECT®) in a Pediatric Population in Non-endemic Countries
Condition: Encephalitis
Intervention: Biological: IC51
10 Completed
Has Results
Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis.
Conditions: Encephalitis;   Japanese Encephalitis
Interventions: Biological: ChimeriVax-JE, Japanese Encephalitis vaccine;   Biological: 0.9% Saline
11 Completed
Has Results
Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers
Conditions: Japanese Encephalitis;   Measles;   Mumps;   Rubella
Intervention: Biological: Japanese encephalitis chimeric virus: Measles, mumps, and rubella live attenuated virus
12 Completed Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV
Conditions: Japanese Encephalitis;   Varicella
Interventions: Biological: Japanese encephalitis chimeric virus;   Biological: Varicella vaccine
13 Completed Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy Subjects
Condition: Japanese Encephalitis
Intervention: Biological: Live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®)
14 Active, not recruiting A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese Infants
Condition: Encephalitis
Interventions: Biological: 0.5ml experimental vaccine on day 0,7 Vero cell-derived inactivated Japanese Encephalitis vaccine;   Biological: 0.5ml experimental vaccine on day 0,28 Vero cell-derived inactivated Japanese Encephalitis vaccine;   Biological: 0.5ml active comparator vaccine on day 0,7 inactivated freeze-dried Japanese Encephalitis vaccine(Vero cell)
15 Enrolling by invitation Seroepidemiology of Japanese Encephalitis Virus Infection in Hualien, Taiwan
Condition: Japanese Encephalitis
Intervention:
16 Completed
Has Results
Long Term Treatment of Herpes Simplex Encephalitis (HSE) With Valacyclovir
Condition: Encephalitis
Interventions: Drug: Valacyclovir;   Drug: Placebo
17 Completed Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines
Conditions: Measles;   Rubella;   Japanese Encephalitis
Interventions: Biological: Measles-Rubella combined vaccine(MR);   Biological: Japanese Encephalitis alive vaccine(JE)
18 Completed
Has Results
Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children
Condition: Encephalitis, Japanese B
Intervention: Biological: JEVAC
19 Completed
Has Results
Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children
Conditions: Japanese Encephalitis;   Hepatitis A
Interventions: Biological: Japanese encephalitis vaccine (Day 0) Hepatitis A vaccine (Day 28);   Biological: Hepatitis A vaccine (Day 0) Japanese encephalitis vaccine (Day 28)
20 Unknown  Postencephalitic Symptoms After Tick Borne Encephalitis
Condition: Central European Encephalitis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years